Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor
Status:
Terminated
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if giving Avastin (bevacizumab) with
standard chemotherapy and a blood stem cell transplant, in patients with an advanced solid
tumor, can help to shrink the tumor or slow its growth. The safety of this treatment will
also be studied.